These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 4968539)
1. Mycobacterial suppression of delayed hypersensitivity in experimental allergic encephalomyelitis. Lisak RP; Kies MW Proc Soc Exp Biol Med; 1968 May; 128(1):214-8. PubMed ID: 4968539 [No Abstract] [Full Text] [Related]
2. Delayed hypersensitivity to myelin basic protein in the passive transfer of experimental allergic encephalomyelitis. Falk GA; Kies MW; Alvord EC J Immunol; 1968 Oct; 101(4):638-44. PubMed ID: 4971475 [No Abstract] [Full Text] [Related]
3. CELLULAR ACTIVITIES IN HYPERSENSITIVE REACTIONS. IV. SPECIFICALLY REACTIVE CELLS IN DELAYED HYPERSENSITIVITY: ALLERGIC ENCEPHALOMYELITIS. RAUCH HC; RAFFEL S J Immunol; 1964 Dec; 93():960-4. PubMed ID: 14241771 [No Abstract] [Full Text] [Related]
4. Complete Freund's adjuvant-induced immune prevention against experimental allergic encephalomyelitis in guinea pigs: early appearance of anti-myelin basic protein antibody. Akiyama K; Murakami T; Nomaguchi TA; Nagai Y Jpn J Exp Med; 1981 Apr; 51(2):137-9. PubMed ID: 6168789 [No Abstract] [Full Text] [Related]
5. Immune responses to myelin basic protein in mycobacterial-induced suppression of experimental allergic encephalomyelitis. Lisak RP; Zweiman B Cell Immunol; 1974 Nov; 14(2):242-54. PubMed ID: 4143110 [No Abstract] [Full Text] [Related]
6. Dissociation of antibody production from disease suppression in the inhibition of allergic encephalomyelitis by myelin basic protein. Lisak RP; Falk GA; Heinze RG; Kies MW; Alvord EC J Immunol; 1970 Jun; 104(6):1435-46. PubMed ID: 4986769 [No Abstract] [Full Text] [Related]
7. Immune protection against experimental autoimmune encephalomyelitis: optimal conditions and analysis of mechanism. Coates A; Mackay IR; Crawford M Cell Immunol; 1974 Jun; 12(3):370-81. PubMed ID: 4142423 [No Abstract] [Full Text] [Related]
8. STRAIGHT CHAIN HYDROCARBONS AS SUBSTITUTES FOR THE OIL IN FREUND'S ADJUVANTS IN THE PRODUCTION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG. SHAW CM; ALVORD EC; KIES MW J Immunol; 1964 Jan; 92():24-7. PubMed ID: 14139542 [No Abstract] [Full Text] [Related]
9. AN ANALYSIS OF COMPONENTS OF FREUND'S ADJUVANTS IN THE PRODUCTION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG. ALVORD EC; SHAW CM; FAHLBERG WJ; KIES MW Z Immunitats Allergieforsch; 1964 Mar; 126():193-208. PubMed ID: 14185397 [No Abstract] [Full Text] [Related]
10. In vitro response to basic protein in experimental allergic encephalomyelitis: effect of pretreatment with basic protein in incomplete adjuvant. Lisak RP; Zweiman B; Dzida L; Rosenblum F; Rorke LB; Barger G Cell Immunol; 1980 Jul; 52(2):443-50. PubMed ID: 6159988 [No Abstract] [Full Text] [Related]
11. Relationships between antibodies and experimental allergic encephalomyelitis. V. Antibodies and delayed hypersensitivity in production and prevention of experimental allergic encephalomyelitis. Alvord EC; Shaw CM; Lisak RP; Falk GA; Kies MW Int Arch Allergy Appl Immunol; 1970; 38(4):403-12. PubMed ID: 4984466 [No Abstract] [Full Text] [Related]
12. Significance of the quantitative relationships of antigen and adjuvant for the efficiency of the adjuvant. Tanaka A Int Arch Allergy Appl Immunol; 1969; 36():Suppl:310-27. PubMed ID: 4984657 [No Abstract] [Full Text] [Related]
13. Autoimmune diseases and thalidomide. II. Adjuvant disease, experimental allergic encephalomyelitis and experimental allergic neuritis of the rat. Goihman-Yahr M; Requena MA; Vallecalle-Suegart E; Convit J Int J Lepr Other Mycobact Dis; 1974; 42(3):266-75. PubMed ID: 4218599 [No Abstract] [Full Text] [Related]
14. ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY. ALVORD EC; SHAW CM; HRUBY S; KIES MW Ann N Y Acad Sci; 1965 Mar; 122():333-45. PubMed ID: 14313493 [No Abstract] [Full Text] [Related]
15. [Induction and prevention of allergic experimental encephalomyelitis in guinea pigs. Relationship with in vitro induced injuries and with class and specificity of the autoantibodies produced]. Lebar R; Boutry JM; Robineaux R; Voisin GA C R Acad Hebd Seances Acad Sci D; 1973 Mar; 276(10):1635-8. PubMed ID: 4198380 [No Abstract] [Full Text] [Related]
16. Myelin metabolism in vitro in experimental allergic encephalomyelitis. Smith ME J Neurochem; 1969 Jul; 16(7):1099-104. PubMed ID: 5796866 [No Abstract] [Full Text] [Related]
17. [Mechanism of action of an encephalitogenic polypeptide in induction of experimental allergic encephalitis]. Lamoureux G; Carnegie PR; McPherson TA; Mackay IR; Bernard C Ann Inst Pasteur (Paris); 1970 Apr; 118(4):562-74. PubMed ID: 5421297 [No Abstract] [Full Text] [Related]
18. Cell-mediated immunity in experimental allergic encephalomyelitis: cross reactivity between myelin basic protein and mycobacteria antigens. Vandenbark AA; Burger DR; Vetto RM Proc Soc Exp Biol Med; 1975 Apr; 148(4):1233-6. PubMed ID: 48264 [TBL] [Abstract][Full Text] [Related]
19. SUBSTITUTES FOR THE MYCOBACTERIA IN FREUND'S ADJUVANTS IN THE PRODUCTION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG. SHAW CM; ALVORD EC; FAHLBERG WJ; KIES MW J Immunol; 1964 Jan; 92():28-40. PubMed ID: 14139543 [No Abstract] [Full Text] [Related]
20. SYMPOSIUM ON RELATIONSHIP OF STRUCTURE OF MICROORGANISMS TO THEIR IMMUNOLOGICAL PROPERTIES. II. HOST-REACTIVE PROPERTIES OF CELL WALLS AND PROTOPLASM FROM MYCOBACTERIA. LARSON CL; BELL JF; LIST RH; RIBI E; WICHT WC Bacteriol Rev; 1963 Dec; 27(4):341-51. PubMed ID: 14097344 [No Abstract] [Full Text] [Related] [Next] [New Search]